Neupogen Sales Data

Rank 70 Current sales rank, all
U.S. Pharmaceuticals.

Last updated: February 2014 (updated quarterly).
The following data shows Neupogen U.S. retail sales in Q4 2013 compared to previous quarters.

Date Range Sales Rank Sales ($000) Units (000)
Q4 2013 70 (5) -2.70% -5.77%
Q3 2013 65 (2) 1.60% -4.88%
Q2 2013 67 (4) -3.07% 0.61%
Q1 2013 63 (4) 3.86% -4.12%
Q4 2012 67 (7) -7.01% -3.95%
Q3 2012 60 (2) 2.65%
Q2 2012 62 (8) 1.50% 4.12%
Q1 2012 70 0.06% -2.86%
Q4 2011 70 (5) 0.16% 10.76%
Q3 2011 65 (5) 0.69% 0.64%
Q2 2011 70 (4) 2.51% 0.64%
Q1 2011 74

* Units refer to the number of packages sold.

Source: IMS Health (Midas). Please review our terms of use and attribution guidelines. Copyright - All rights reserved. Unauthorized use and/or duplication of this material without express written permission is strictly prohibited.

Hide
(web2)